404 related articles for article (PubMed ID: 10701389)
1. Pharmaceutical policies in Canada: another example of federal-provincial discord.
Anis AH
CMAJ; 2000 Feb; 162(4):523-6. PubMed ID: 10701389
[TBL] [Abstract][Full Text] [Related]
2. Points to consider about prescription drug prices: an overview of federal policy and pricing studies.
Kucukarslan S; Hakim Z; Sullivan D; Taylor S; Grauer D; Haugtvedt C; Zgarrick D
Clin Ther; 1993; 15(4):726-38. PubMed ID: 8221823
[TBL] [Abstract][Full Text] [Related]
3. Do provincial drug benefit initiatives create an effective policy lab? The evidence from Canada.
Pomey MP; Morgan S; Church J; Forest PG; Lavis JN; McIntosh T; Smith N; Petrela J; Martin E; Dobson S
J Health Polit Policy Law; 2010 Oct; 35(5):705-42. PubMed ID: 21123668
[TBL] [Abstract][Full Text] [Related]
4. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
Openshaw MS
Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
[TBL] [Abstract][Full Text] [Related]
5. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
6. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
7. Economic aspects of the new Spanish laws on pharmaceutical preparations.
Antoñanzas F; Oliva J; Pinillos M; Juàrez C
Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical policy in Italy: towards a structural change?
Ghislandi S; Krulichova I; Garattini L
Health Policy; 2005 Apr; 72(1):53-63. PubMed ID: 15760698
[TBL] [Abstract][Full Text] [Related]
9. Realizing two-tiered innovation policy through drug regulation.
Ridgway WE
Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
[No Abstract] [Full Text] [Related]
10. Health policy or intellectual property policy? The fight over Bill C-91. Canadian Healthcare Association.
Int J Health Care Qual Assur Inc Leadersh Health Serv; 1997; 10(2-3):vii-x. PubMed ID: 10169229
[TBL] [Abstract][Full Text] [Related]
11. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
Mintzes B; Barer M; Lexchin J; Bassett KL
Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical policy in China.
Sun Q; Santoro MA; Meng Q; Liu C; Eggleston K
Health Aff (Millwood); 2008; 27(4):1042-50. PubMed ID: 18607039
[TBL] [Abstract][Full Text] [Related]
13. Do higher drug costs lead to better health?
Mintzes B; Lexchin J
Can J Clin Pharmacol; 2005; 12(1):e22-7. PubMed ID: 16055941
[TBL] [Abstract][Full Text] [Related]
14. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals.
Meng Q; Cheng G; Silver L; Sun X; Rehnberg C; Tomson G
Health Policy Plan; 2005 May; 20(3):185-96. PubMed ID: 15840634
[TBL] [Abstract][Full Text] [Related]
15. The impact of reference-pricing systems in Europe: a literature review and case studies.
Dylst P; Vulto A; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):729-37. PubMed ID: 22098289
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceuticals and medical devices: business practices. Issue brief.
Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448
[No Abstract] [Full Text] [Related]
17. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
18. The pricing of pharmaceuticals: an international comparison.
Dickson M
Clin Ther; 1992; 14(4):604-10; discussion 603. PubMed ID: 1525794
[TBL] [Abstract][Full Text] [Related]
19. Should drug prices be negotiated under part D of Medicare? And if so, how?
Frank RG; Newhouse JP
Health Aff (Millwood); 2008; 27(1):33-43. PubMed ID: 18180478
[TBL] [Abstract][Full Text] [Related]
20. [Policies concerning pharmaceutical prices and reimbursement in Mexico, Organization for Co-operation and Economic Development. 2007].
Moïse P; Docteur E
Salud Publica Mex; 2008; 50 Suppl 4():S504-10. PubMed ID: 19082262
[No Abstract] [Full Text] [Related]
[Next] [New Search]